Effectiveness and Tolerability of Eptinezumab

The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of eptinezumab as preventive migraine treatment in a cohort of episodic or chronic migraine patients.

Inclusion Criteria: * Diagnosis of migraine without aura, migraine with aura, or chronic migraine according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III); * Good compliance to study procedures; * Availability of headache diary at least of the preceding months before enrolment; * At least 8 monthly migraine days. Exclusion Criteria: * Subjects with contraindications for use of eptinezumab; * Concomitant diagnosis of medical diseases and/or comorbidities that, in the Investigator's opinion might interfere with study assessments; * medical comorbidities that could interfere with study results; * Pregnancy and breastfeeding * Changes in preventive treatments in the month before the first administration of eptinezumab